Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 1
1957 1
1960 3
1961 2
1963 1
1965 2
1966 1
1967 2
1968 4
1969 1
1970 6
1971 2
1972 6
1973 3
1974 1
1975 1
1976 1
1977 3
1978 2
1980 4
1981 7
1982 7
1983 6
1984 5
1985 2
1986 6
1987 8
1988 7
1989 19
1990 9
1991 8
1992 11
1993 11
1994 12
1995 16
1996 22
1997 29
1998 23
1999 33
2000 26
2001 26
2002 34
2003 43
2004 42
2005 40
2006 47
2007 56
2008 62
2009 90
2010 68
2011 94
2012 94
2013 98
2014 117
2015 119
2016 95
2017 104
2018 116
2019 123
2020 158
2021 185
2022 202
2023 196
2024 180
2025 120

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,501 results

Results by year

Filters applied: . Clear all
Page 1
New Advances in Metabolic Syndrome.
Rizzo M, Rizvi AA. Rizzo M, et al. Int J Mol Sci. 2024 Jul 30;25(15):8311. doi: 10.3390/ijms25158311. Int J Mol Sci. 2024. PMID: 39125880 Free PMC article.
Severe combined immunodeficiency diagnosis and genetic defects.
Aranda CS, Gouveia-Pereira MP, da Silva CJM, Rizzo MCFV, Ishizuka E, de Oliveira EB, Condino-Neto A. Aranda CS, et al. Among authors: rizzo mcfv. Immunol Rev. 2024 Mar;322(1):138-147. doi: 10.1111/imr.13310. Epub 2024 Jan 29. Immunol Rev. 2024. PMID: 38287514 Review.
Anticoagulation and Bleeding during Veno-Venous Extracorporeal Membrane Oxygenation: Insights from the PROTECMO Study.
Martucci G, Giani M, Schmidt M, Tanaka K, Tabatabai A, Tuzzolino F, Agerstrand C, Riera J, Ramanan R, Grasselli G, Ait Hssain A, Gannon WD, Buabbas S, Gorjup V, Trethowan B, Rizzo M, Fanelli V, Jeon K, De Pascale G, Combes A, Ranieri MV, Duburcq T, Foti G, Chico JI, Balik M, Broman LM, Schellongowski P, Buscher H, Lorusso R, Brodie D, Arcadipane A; International ECMO Network (ECMONet). Martucci G, et al. Among authors: rizzo m. Am J Respir Crit Care Med. 2024 Feb 15;209(4):417-426. doi: 10.1164/rccm.202305-0896OC. Am J Respir Crit Care Med. 2024. PMID: 37943110 Free article.
Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Diabetes and Non-Alcoholic Fatty Liver Disease-Current Evidence.
Muzurović EM, Volčanšek Š, Tomšić KZ, Janež A, Mikhailidis DP, Rizzo M, Mantzoros CS. Muzurović EM, et al. Among authors: rizzo m. J Cardiovasc Pharmacol Ther. 2022 Jan-Dec;27:10742484221146371. doi: 10.1177/10742484221146371. J Cardiovasc Pharmacol Ther. 2022. PMID: 36546652 Free article. Review.
Safety and efficacy of the new, oral, small-molecule, GLP-1 receptor agonists orforglipron and danuglipron for the treatment of type 2 diabetes and obesity: systematic review and meta-analysis of randomized controlled trials.
Karakasis P, Patoulias D, Pamporis K, Stachteas P, Bougioukas KI, Klisic A, Fragakis N, Rizzo M. Karakasis P, et al. Among authors: rizzo m. Metabolism. 2023 Dec;149:155710. doi: 10.1016/j.metabol.2023.155710. Epub 2023 Oct 16. Metabolism. 2023. PMID: 37852529
2,501 results